Arterial resection at the time of pancreatectomy for cancer

Surgery (United States)

Volumn 155, Issue 5, 2014, Pages 919-926

  Christians, Kathleen K ^a   Pilgrim, Charles H C ^a   Tsai, Susan ^a   Ritch, Paul ^a   George, Ben ^a   Erickson, Beth ^a   Tolat, Parag ^a   Evans, Douglas B ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CA 19-9 ANTIGEN; CAPECITABINE; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; IRINOTECAN; OXALIPLATIN; PACLITAXEL;

ADULT; AGED; ARTERIAL RESECTION; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CELIAC ARTERY; CLINICAL ASSESSMENT; FEMALE; FOLLOW UP; GASTRODUODENAL ARTERY; HOSPITALIZATION; HUMAN; LAPAROSCOPY; LAPAROTOMY; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PERITONEAL DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADULT; AGED; BLOOD LOSS, SURGICAL; CELIAC ARTERY; FEMALE; FOLLOW-UP STUDIES; HEPATIC ARTERY; HUMANS; LENGTH OF STAY; MALE; MESENTERIC ARTERIES; MIDDLE AGED; OPERATIVE TIME; PANCREAS; PANCREATECTOMY; PANCREATIC NEOPLASMS; PATIENT SELECTION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 84899659181     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2014.01.003     Document Type: Article

References (18)

1. J.G. Fortner Regional resection of cancer of the pancreas: a new surgical approach Surgery 73 1973 307 320
2. J.F. Tseng, C.P. Raut, and J.E. Lee et al. Pancreaticoduodenectomy with vascular resection: margin status and survival duration J Gastrointest Surg 8 2004 935 949
3. M.H. Katz, H. Wang, and J.B. Fleming et al. Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma Ann Surg Oncol 16 2009 836 847
4. D.B. Evans, M.B. Farnell, K.D. Lillemoe, C. Vollmer Jr., S.M. Strasberg, and R.D. Schulick Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement Ann Surg Oncol 16 2009 1736 1744
5. K.K. Christians, K. Riggle, and R. Keim et al. Distal splenorenal and temporary mesocaval shunting at the time of pancreatectomy for cancer: Initial experience from the Medical College of Wisconsin Surgery 154 2013 123 131
6. Y. Yamamoto, Y. Sakamoto, and D. Ban et al. Is celiac axis resection justified for T4 pancreatic body cancer? Surgery 151 2012 61 69
7. N. Mollberg, N.N. Rahbari, and M. Koch et al. Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis Ann Surg 254 2011 882 893
8. K.K. Christians, S. Tsai, P.P. Tolat, and D.B. Evans Critical steps for pancreaticoduodenectomy in the setting of pancreatic adenocarcinoma J Surg Oncol 107 2013 33 38
9. S. Edge, D.R. Byrd, and C.C. Compton et al. AJCC cancer staging manual 7th ed. 2010 Springer Chicago 243
10. D.B. Evans, K.K. Christians, and W.D. Foley Pancreaticoduodenectomy (Whipple operation) and total pancreatectomy for cancer J.L. Fischer, Mastery of surgery 6th ed 2012 Wolters Kluwer/Lippincott Williams & Wilkins Philadelphia 1445 1466
11. B.L. Appel, P. Tolat, D.B. Evans, and S. Tsai Current staging systems for pancreatic cancer Cancer J 18 2012 539 549
12. D.B. Evans, B.A. Erickson, and P. Ritch Borderline resectable pancreatic cancer: definitions and the importance of multimodality therapy Ann Surg Oncol 17 2010 2803 2805
13. M.H. Katz, P.W. Pisters, and D.B. Evans et al. Borderline resectable pancreatic cancer: the importance of this emerging stage of disease J Am Coll Surg 206 2008 833 846
14. R.A. Abrams, A.M. Lowy, E.M. O'Reilly, R.A. Wolff, V.J. Picozzi, and P.W. Pisters Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement Ann Surg Oncol 16 2009 1751 1756
15. NCCN Guidelines(R) Updates J Natl Compr Canc Netw 11 May 1 2013 xxxiv xxxvi
16. D.B. Evans, C.H. Crane, C. Charnsangavej, and R.A. Wolff The added value of multidisciplinary care for patients with pancreatic cancer Ann Surg Oncol 15 2008 2078 2080
17. C.M. Kang, Y.E. Chung, and J.Y. Park et al. Potential contribution of preoperative neoadjuvant concurrent chemoradiation therapy on margin-negative resection in borderline resectable pancreatic cancer J Gastrointest Surg 16 2012 509 517
18. Christians KK, Tsai S, Mahmoud A, et al. Neoadjuvant FOLFIRINOX for borderline resectable pancreas cancer - a new treatment paradigm. Oncologist. In press.